Get the Stockscreener App
82.68
1.46%
1.19
After Hours:
82.67
-0.01
-0.01%
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp stock is traded at $82.68, with a volume of 6.42M.
It is up +1.46% in the last 24 hours and up +5.51% over the past month.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
See More
Previous Close:
$81.49
Open:
$80.99
24h Volume:
6.42M
Relative Volume:
0.88
Market Cap:
$104.96B
Revenue:
$393.94B
Net Income/Loss:
$428.00M
P/E Ratio:
216.10
EPS:
0.3826
Net Cash Flow:
$6.29B
1W Performance:
+1.62%
1M Performance:
+5.51%
6M Performance:
+35.36%
1Y Performance:
+56.03%
1-Day Range:
$80.76
$82.68
1-Week Range:
$77.59
$82.68
52-Week Range:
$52.69
$85.15
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health Corp
Sector
Industry
Phone
(401) 765-1500
Address
ONE CVS DR., WOONSOCKET
Compare CVS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
82.68 | 103.45B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
UNH
Unitedhealth Group Inc
|
354.47 | 315.01B | 435.16B | 18.37B | 17.37B | 19.16 |
|
ELV
Elevance Health Inc
|
372.24 | 82.20B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
280.39 | 73.44B | 268.22B | 6.55B | 7.44B | 22.67 |
|
HUM
Humana Inc
|
266.29 | 32.55B | 126.36B | 1.30B | 1.55B | 10.67 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-14-25 | Initiated | Goldman | Buy |
| Aug-18-25 | Upgrade | UBS | Neutral → Buy |
| Aug-14-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-13-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-12-25 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jan-30-25 | Upgrade | Edward Jones | Hold → Buy |
| Dec-03-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Nov-18-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-04-24 | Upgrade | TD Cowen | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| May-07-24 | Downgrade | TD Cowen | Buy → Hold |
| May-02-24 | Downgrade | UBS | Buy → Neutral |
| May-01-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-01-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Dec-22-23 | Initiated | HSBC Securities | Buy |
| Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| May-26-23 | Initiated | Piper Sandler | Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-14-21 | Initiated | Goldman | Buy |
| Dec-01-21 | Initiated | Seaport Research Partners | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
| Sep-17-20 | Initiated | Piper Sandler | Overweight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
| Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-10-19 | Reiterated | BofA/Merrill | Buy |
| Mar-13-19 | Initiated | Bernstein | Outperform |
| Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-18-18 | Initiated | Barclays | Overweight |
| Nov-29-18 | Resumed | Goldman | Neutral |
| Nov-28-18 | Initiated | Evercore ISI | Outperform |
| Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
| Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
Cvs Health Corp Stock (CVS) Latest News
FDA Issues Alert on CVS Wound Gel Due to Safety Concerns - GuruFocus
US lawmakers press health insurance executives on affordability - Reuters
Backpack Healthcare now available to Aetna Better Health of Illinois members - Drug Store News
CVS Health (CVS) Aims to Streamline Prior Authorization Processes - GuruFocus
CVS Health (CVS) Plans to Standardize Prior Authorization Processes to Ensure Seamless Patient Care - Intellectia AI
CVS says 85% of Americans live near its stores as drug changes save $1.3B - Stock Titan
Universal Beteiligungs und Servicegesellschaft mbH Has $62.59 Million Stake in CVS Health Corporation $CVS - MarketBeat
UnitedHealth CEO Says Hospitals, Drug Prices Drive US Health Care Costs, Pledges ACA Rebates - Benzinga
CVS Health (CVS) Under Antitrust Scrutiny by Lawmakers - GuruFocus
CVS, UnitedHealth, Express Scripts Duck PBM Antitrust Suit - Law360
Should you buy CVS Health stock before Feb. 10? - MSN
CVS Health May Have Violated Antitrust Laws, Republican Lawmakers Say - Bloomberg.com
Should You Buy CVS Health Stock Before Feb. 10? - Finviz
UnitedHealth to offer rebates to its Obamacare customers - Reuters
Judge Tosses Drug Pricing Conspiracy Case Against CVS, UnitedHealth, Evernorth - PYMNTS.com
CVS Health Sees Unusually Large Options Volume (NYSE:CVS) - MarketBeat
CVS reverses course on closing Van Ness pharmacy in San Francisco - The Business Journals
Improving postpartum care with mobile Women & Infants Hospital - CVS Health
UnitedHealth, CVS Fend Off Antitrust Lawsuit Over Drug Costs - Bloomberg Law News
UnitedHealth plans to rebate exchange profits to customers - Modern Healthcare
CVS Health agrees to cover new HIV prevention drug - epgn.com
How CVS Health’s Dividend And Medicare Focus At CVS (CVS) Has Changed Its Investment Story - Yahoo Finance
Ex-Dividend Reminder: Colgate-Palmolive, Lowe's Companies and CVS Health - Nasdaq
NorthCrest Asset Manangement LLC Cuts Stock Holdings in CVS Health Corporation $CVS - MarketBeat
WEI Named 2025 CVS Health Supplier Star of the Year - progress-index.com
Allstate Corp Buys Shares of 46,721 CVS Health Corporation $CVS - MarketBeat
Nippon Life Global Investors Americas Inc. Boosts Stake in CVS Health Corporation $CVS - MarketBeat
PBMs Seek Exit From Philly's Suit Over Opioid Crisis - Law360
CVS Health Corporation (CVS) Board Approves Quarterly Dividend As Cantor Fitzgerald and Bernstein Assert Bullishness - Finviz
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga
Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks' - Benzinga
CVS Health offering MMR vaccine at Ohio pharmacy locations - WFMJ.com
CVS Health (CVS) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
CVS Ducks Antitrust But Not Biz Interference Claim At 5th Circ. - Law360
CVS Has Standing to Pursue Amitiza Antitrust Claims, Court Says - Bloomberg Law News
WNC & Associates, Freeport Housing Trust, Best Apartments, Inc. and CVS Health Break Ground on Varney Heights, a 42-Unit Senior Housing Community in Freeport, Maine - Yahoo Finance
CVS Health sets Feb. 10 earnings webcast on Q4 and 2025 financial results - Stock Titan
Manning & Napier Advisors LLC Sells 57,032 Shares of CVS Health Corporation $CVS - MarketBeat
CVS, Caremark Prevail in Appeal of Pharmacy Benefit Lawsuit - Bloomberg Law News
CVS Health Foundation Grants the American Diabetes Association $2.6 Million to Expand Maternal Diabetes Program Across Two Additional NYC Communities - Finviz
CVS/Aetna Medicare Advantage Plans Policy Holders Have Opportunity to Join Investigation into Improper Claim Denial for Post-Acute Care with the Schall Law Firm - GlobeNewswire Inc.
10 Biggest Healthcare Companies - Investopedia
Earnings Preview: What To Expect From CVS Health's Report - Barchart.com
$2.6M diabetes grant backs healthier pregnancies in NYC communities - Stock Titan
Could CVS Health Corporation's (NYSE:CVS) Weak Financials Mean That The Market Could Correct Its Share Price? - Yahoo Finance
CVS Health Corp (NYSE:CVS) Shows Top Technical Rating and Superior Setup for Potential Breakout - Chartmill
CVS Health Foundation Grants $2.6M to Expand Maternal Diabetes Program - CVS Health
Risk Report: Can CVS Health Corporation generate free cash flowJuly 2025 Reactions & Accurate Entry/Exit Alerts - baoquankhu1.vn
Global Wealth Management Investment Advisory Inc. Takes $4.59 Million Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Canal Insurance CO - MarketBeat
CVS Health Corp.: How a Pharmacy Giant Is Rebuilding the Front Door to U.S. Healthcare - AD HOC NEWS
Cvs Health Corp Stock (CVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
1.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):